ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients

Affiliations

• ¹ Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
• ² The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
• ³ Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
• ⁴ Department of Medicine, Division of Rheumatology, Eulji University Hospital, Daejeon, Republic of Korea.
• ⁵ Department of Medicine/Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ⁶ National Institute of Arthritis and Musculoskeletal and Skin Diseases, US National Institutes of Health, Bethesda, Maryland, USA.
• ⁷ Department of Rheumatology and Clinical Immunogenetics, University of Texas Health Science Center at Houston, Houston, Texas, USA.
• ⁸ INSERM U1173, UFR Simone Veil, Versailles-Saint-Quentin University, Laboratoire d'Excellence INFLAMEX, France Genetics Division, Ambroise Paré Hospital (AP-HP), Boulogne-Billancourt, Paris, France.
• ⁹ INSERM U1173, UFR Simone Veil, Versailles-Saint-Quentin University, Laboratoire d'Excellence INFLAMEX, France.
• ¹⁰ School of Medicine, University of Western Australia, Western Australia, Perth, Australia Department of Rheumatology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
• ¹¹ Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway Department of Immunology, Oslo University Hospital, Oslo, Norway.
• ¹² Department of Rheumatology, University Hospital Oslo, Oslo, Norway.
• ¹³ Centre for Vascular Prevention, Danube-University Krems, Krems, Austria. Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland King Abdulaziz University, Jeddah, Saudi Arabia.
• ¹⁴ Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
• ¹⁵ Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
• ¹⁶ Department of Rheumatology, Ghent University Hospital, Ghent, Belgium VIB Inflammation Research Center, Ghent, Belgium.
• ¹⁷ Department of Rheumatology, Faculty of Medicine, Hospital General de México, Universidad Nacional Autónoma de México, Mexico City, México.
• ¹⁸ University of California, San Francisco, California, USA.
• ¹⁹ Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
• ²⁰ Division of Rheumatology, Toronto Western Hospital, Toronto, Ontario, Canada.
• ²¹ Rheumatology Department, Hospital Puerta de Hierro, Madrid, Spain.
• ²² Rheumatology Department, Complejo Hospitalario La Coruña, Instituto de Investigación Biomédica A Coruña (INIBIC), La Coruña, Spain.
• ²³ Rheumatology Department, Hospital Marqués de Valcecilla, Instituto de Formación e Investigación Marqués de Valcecillas (IFIMAV), Santander, Spain.
• ²⁴ Department of Immunology, Asturias Central University Hospital, Oviedo, Spain Fundación Renal Iñigo Alvarez de Toledo, Madrid, Spain.
• ²⁵ National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, Oxford, UK.
• ²⁶ Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK.
• ²⁷ Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
• ²⁸ Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada Toronto Western Research Institute, Toronto, Ontario, Canada Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada.
• ²⁹ Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
• ³⁰ Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
• ³¹ Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
• ³² Department of Medicine, Division of Allergy, Immunology, Rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan. School of Medicine, National Yang- Ming University, Taipei, Taiwan.
• ³³ SpA Group Hospital Militar, Universidad Militar Nueva Granada, Bogotá, Colombia.
• ³⁴ Helgelandssykehuset, Mo i Rana, Norway.
• ³⁵ Chronic Diseases Research Centre (CEDOC), Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
• ³⁶ Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain.
• ³⁷ INSERM U1173, UFR Simone Veil, Versailles-Saint-Quentin University, Laboratoire d'Excellence INFLAMEX, France Division of Rheumatology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, Paris, France.
• ³⁸ The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia MRC Integrative Epidemiology Unit, University of Bristol, UK School of Social and Community Medicine, University of Bristol, Bristol, UK.